Tobam’s Eli Lilly & Co Position
Does Tobam own Eli Lilly & Co (LLY)? Yes — 6.7K shares worth $6M (+1.60% of its 13F portfolio) as of Q1 2026, up from 3.0K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
6.7K
% of Portfolio
+1.60%
Quarters Held
25
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 6.7K | $6M | +1.60% |
| Q3 2025 | 3.0K | $2M | +0.84% |
| Q2 2025 | 3.4K | $3M | +1.04% |
| Q1 2025 | 5.1K | $4M | +1.78% |
| Q4 2024 | 8.5K | $7M | +2.00% |
| Q3 2024 | 14.8K | $13M | +2.39% |
| Q2 2024 | 22.2K | $20M | +3.15% |
| Q1 2024 | 43.6K | $34M | +3.04% |
| Q4 2023 | 56.9K | $33M | +2.90% |
| Q3 2023 | 58.5K | $31M | +2.52% |
| Q2 2023 | 40.2K | $19M | +1.42% |
| Q1 2023 | 65.1K | $22M | +1.47% |
| Q4 2022 | 83.4K | $31M | +2.02% |
| Q3 2022 | 92.1K | $30M | +2.08% |
| Q2 2022 | 110.7K | $36M | +2.25% |
| Q1 2022 | 184.3K | $53M | +2.65% |
| Q4 2021 | 209.0K | $58M | +2.60% |
| Q3 2021 | 236.5K | $55M | +2.32% |
| Q2 2021 | 217.4K | $50M | +2.00% |
| Q1 2021 | 103.0K | $19M | +0.82% |
| Q4 2020 | 3.0K | $513,000 | +0.02% |
| Q3 2020 | 2.9K | $429,000 | +0.02% |
| Q2 2019 | 7.1K | $781,000 | +0.04% |
| Q1 2019 | 6.1K | $790,000 | +0.04% |
| Q4 2018 | 16.7K | $2M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tobam’s full portfolio or all institutional holders of LLY.